T: 1300 680 898
Medical Instrument Disinfection
Chlorine dioxide is a broad spectrum biocide with proven activity against bacteria, viruses, yeasts, mycobacteria and bacterial spores in short contact times.
Our Resources menu contains a wide range of training tools, publications, guidelines and case studies. If you can't find what you're looking for, then please contact Tristel.
With cleaning not equating to appropriate disinfection; low-level disinfection covering only a limited range of microorganisms and high-level disinfection being impractical or time-consuming, intermediate-level disinfection provides the answer. Click to read more!
Available in a Gel or Liquid, Tristel Jet products are effective against coronaviruses including SARS-CoV-2. They are fast and easy-to-use chlorine dioxide-based solutions for the sporicidal disinfection of near-patient surfaces. Click to read more!
Stella is an automated system designed specifically for the decontamination of small- and medium-sized, rigid and flexible, single-lumened and non-lumened semi-critical medical devices. Stella combines the simplicity of manual soaking with the sophistication of a fully automated washer disinfector. Click here to read more!
The Tristel Trio Wipes System is a three-part decontamination system for non-lumened medical devices. It comprises three wipes which in sequence perform the steps of the decontamination procedure in a matter of minutes. Click here to read more!
Tristel plc has a consistent record of revenue growth as an AIM listed public company. It is one of only a few businesses worldwide that specialises in infection prevention in human and animal healthcare and contamination control in industry. Since its IPO in June 2005, Tristel has established itself as a world class manufacturer of liquid chemical hygiene products.
- RANZCOG ASM (Hobart, 13-17 February)
- ASCCP Scientific Meeting (Perth, 15-18 April)
- ASA Conference (Brisbane, 28-30 May)
- EMUGS Conference (Queenstown NZ, 12-14 August)
- ASUM 50th Anniversary Conference (Sydney, 19-21 November)
The Tristel story began in 1993 when the founding shareholders developed a proprietary chlorine dioxide formulation to be used for the disinfection of flexible endoscopes to replace glutaraldehyde.